Q-omics provides the consensus-scored PGAM2 profile across patient tissues and cancer cell-line models. Additionally, PGAM2 protein abundance shows 17,437 significant protein co-abundance associations, with the highest sampling consensus in HNSC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for PGAM2 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with PGAM2 in patient tissues and cancer cell lines. In patient samples, PGAM2 shows the broadest associations at the RNA and protein expression levels, with HNSC recurring as the lineage with the largest associated feature set. In cancer cell lines, PGAM2 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in OESOPHAGUS, while CRISPR and shRNA rows add functional-dependency signals in LUNG_NSCLC_LUAD and BLOOD_Leukemia.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼Protein (mass-spec)
Protein (mass-spec)	17,437	HNSC (7282)	view →
RNA	5,615	HNSC (1413)	view →
▼RNA
RNA	1,652	SCLC (1652)	view →
Function (RNA)	596	SCLC (596)	view →
▼Mutation
RNA	267	UCEC (93)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼CRISPR
CRISPR	1,735	OESOPHAGUS (154)	view →
RNA	1,423	LUNG_NSCLC_LUAD (175)	view →
▼RNA
RNA	6,488	BLOOD_Leukemia (4449)	view →
Function (RNA)	2,293	BLOOD_Leukemia (1424)	view →
▼Mutation
Mutation	2,491	BLOOD_Leukemia (2118)	view →
RNA	10	BLOOD_Leukemia (8)	view →
▼shRNA
shRNA	1,517	OESOPHAGUS (252)	view →
RNA	1,431	BREAST (448)	view →